Grants for City or township governments - Consumer Protection

The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury.Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products.

The FY24 BCRP Clinical Research Extension Award is designed to enhance the impact of previously funded breast cancer clinical studies by extending or expanding data collection, follow-up, and analysis. This mechanism directly aligns with the broader mission of maximizing the value of breast cancer patient participation in clinical research, thereby addressing knowledge gaps that may arise from early trial termination, limited patient follow-up, or insufficient data collection and analysis. By ensuring that the invaluable contributions of patient tissues, serum, other biological specimens, and data are fully utilized, the BCRP aims to ensure that scientific efforts truly value these contributions and maximize their impact in saving lives. The primary target beneficiaries of this award are breast cancer patients and the scientific community. The impact goals are to increase the clinically relevant impact of breast cancer patient participation, accelerate progress toward ending breast cancer, and generate meaningful hypotheses or support valid conclusions. The program prioritizes research that extends or affects the impact of previous clinical trials or studies, or creates new impact in the fight against breast cancer. It specifically encourages innovative research in nuclear medicine to support early diagnosis, more effective treatment, and improved health outcomes for active-duty Service Members, Veterans, military beneficiaries, and the American public. Key focuses for the research scope include deeper molecular analysis of clinical samples, initiation of new correlative studies, biomarker validation, or continued clinical follow-up of patients in open, ongoing, or completed clinical trials. The proposed research can be hypothesis-testing or -generating, and may also be designed to create clinically annotated and molecularly characterized experimental platforms, such as patient-derived models or tissue arrays. Innovation is not a primary criterion for this award, and projects proposing new clinical trials will not be supported. A critical focus is on meaningful and productive partnerships between investigators, with a Partnering PI Option available to accommodate two Principal Investigators who bring distinct and equally intellectual contributions to the project. Expected outcomes include increased understanding of breast cancer through extended data analysis, validation of biomarkers, improved patient follow-up, and the development of new experimental platforms. Measurable results are tied to valid conclusions from appropriately sized study samples and a clear data-sharing plan to ensure the scientific community has access to generated platforms and molecular data. The program also emphasizes robust research teams with relevant expertise and mandatory involvement of two or more breast cancer consumer advocates who provide objective input on the research's potential impact for individuals with, or at risk for, breast cancer. The overall strategic priority is to accelerate clinical and translational research, especially for advanced state and recurrent patients, and to improve health outcomes for military service members and the public through relevant collaborations and innovative techniques.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit grant applications from neutral, independent institutions and/or organizations to support meetings (e.g., conferences, workgroups, roundtables) that convene a broad range of multiple stakeholders, including those with relevant expertise, to explore, research, and address issues related to medical products, policy, and surveillance methods and systems. Support includes, but is not limited to the design, planning, execution, synthesis, summary, and communication of findings from these forums to a broad range of organizations and individuals.

This grant provides funding to organizations in Texas that promote financial literacy and consumer credit education, helping communities improve their financial stability at little or no cost.

This funding opportunity provides financial support to local public agencies in California to enforce laws against the illegal sale and marketing of tobacco products to minors and youth.

This funding opportunity is designed to support organizations that provide financial education initiatives in Washington State, helping to improve financial literacy among residents.

This funding opportunity provides financial support for a wide range of organizations to develop innovative therapies for ultra-rare cancers, addressing unmet medical needs in this challenging area.

This funding opportunity provides $1.5 million to state, local, territorial, or tribal agencies and nonprofit training organizations partnering with accredited colleges to create a centralized training system for food safety regulation and laboratory education.

This funding opportunity supports a wide range of organizations in researching and developing standardized methods to evaluate and treat heart-related side effects caused by cancer therapies.

This funding opportunity provides financial support to a wide range of organizations for initiatives aimed at improving the detection and monitoring of antibiotic resistance in food products to enhance public health and food safety.

This grant provides funding and resources to organizations seeking to establish or enhance recycling programs, focusing on waste diversion and recycling education.

This funding opportunity provides financial support for institutions and organizations to conduct innovative studies that improve understanding and treatment of rare diseases, addressing significant gaps in knowledge and promoting effective medical product development.

This funding opportunity supports clinical trials for products designed to treat rare diseases, aiming to improve treatment options and outcomes for patients with unmet medical needs.

This funding opportunity supports organizations in New Jersey that provide free assistance to residents seeking health coverage through the state's marketplace, particularly targeting underserved communities and ensuring access to necessary resources and information.